IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
20 hedge funds and large institutions have $3.28M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
$2.21M
Puts
–
Net Calls
+$2.21M
Net Calls Change
+$2.21M
Top Buyers
1 |
RCM
1
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
$1.45M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$209K |
3 |
DMK
3
David M. Knott
|
$207K |
4 |
LA
4
Linden Advisors
New York
|
$169K |
5 |
SC
5
Sculptor Capital
New York
|
$160K |
Top Sellers
No sellers this quarter